AGDx offers targeted gene testing for obesity since March 2018 for clinical diagnostics. The involvement of genetic factors in the development of obesity is estimated to be 40-70%. Several syndromal obesity genes as well as leptin-melanocortin pathway genes are included in this panel. These clinical relevant genes may influence obese patient’ response to weight management. The obesity panel was previously performed using a WES based virtual gene panel at the VU medical center and further developed as an NGS capture panel for economic and reliable screening for inherited obesity. The coverage of this targeted gene panel is > 99%. The purpose of this panel is to offer relevant testing and to make genetic analyses of inherited obesity accessible to all physicians. Since we have many requests for this panel, you can order this panel for a very special economic price.